---
schema_version: "secwatch.filing_event.v1"
accession: "0001746473-25-000159"
form_type: "8-K"
ticker: "PLRX"
cik: "0001746473"
company_name: "PLIANT THERAPEUTICS, INC."
filed_at: "2025-10-24T23:59:59+00:00"
generated_at: "2026-05-17T02:21:07.306825+00:00"
event_type: "leadership"
sentiment: "neutral"
materiality_score: 0.35
calibrated_materiality_score: 0.35
confidence: "high"
source: SEC EDGAR
---

# Pliant Therapeutics CBO Hans Hull resigns effective October 20, 2025

## Summary
- Hans Hull resigned as Chief Business Officer, effective October 20, 2025.
- Resignation was not due to any disagreement on operations, policies, or practices.
- No replacement has been announced as of the filing date.

## SEC filing metadata
- accession: 0001746473-25-000159
- form_type: 8-K
- ticker: PLRX
- cik: 0001746473
- company_name: PLIANT THERAPEUTICS, INC.
- filed_at: 2025-10-24T23:59:59+00:00
- event_type: leadership
- sentiment: neutral
- materiality_score: 0.35
- calibrated_materiality_score: 0.35
- confidence: high
- sec_items: 5.02
- EDGAR index: https://www.sec.gov/Archives/edgar/data/1746473/000174647325000159/0001746473-25-000159-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/1746473/000174647325000159/plrx-20251020.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0001746473-25-000159
- JSON: https://secwatch.observer/filing/0001746473-25-000159.json
- Plain text: https://secwatch.observer/filing/0001746473-25-000159.txt

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.